Marian Gutowski

Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients

André Pèlegrin, A. Pèlegrin, M. Gutowski, 2019, Toxicology reports.

Targeting of Human Breast Cancer by a Bispecific Antibody Directed against Two Tumour-Associated Antigens: ErbB-2 and Carcinoembryonic Antigen

André Pèlegrin, Philippe Rouanet, M. Dorvillius, 2002, Tumor Biology.

Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent

Alexander L. Vahrmeijer, André Pèlegrin, Leonora S. F. Boogerd, 2018, Annals of Surgical Oncology.

SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.

Alexander L Vahrmeijer, André Pèlegrin, A. Vahrmeijer, 2017, Surgical oncology.

Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.

Leonora S F Boogerd, Cornelis J H van de Velde, Alexander L Vahrmeijer, 2018, The lancet. Gastroenterology & hepatology.

Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial

Norbert Ailleres, Philippe Rouanet, David Azria, 2013, Radiation oncology.